These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23764348)

  • 21. Sertraline-induced hyponatremia and seizures in old age.
    Shubrata KS; Narayanaswamy JC; Viswanath B; Rudhran V; Chandrasekhar CR; Math SB
    J Neuropsychiatry Clin Neurosci; 2012; 24(1):E47. PubMed ID: 22450648
    [No Abstract]   [Full Text] [Related]  

  • 22. Bupropion-associated galactorrhea: a case report.
    Çam B; Bilgin AA
    J Clin Psychopharmacol; 2015 Feb; 35(1):113-4. PubMed ID: 25502489
    [No Abstract]   [Full Text] [Related]  

  • 23. Visual and auditory hallucinations with the association of bupropion and valproate.
    Filteau MJ; Leblanc J; Lefrançoise S; Demers MF
    Can J Psychiatry; 2000 Mar; 45(2):198-9. PubMed ID: 10742884
    [No Abstract]   [Full Text] [Related]  

  • 24. Bupropion-induced neck and shoulder pain.
    Sansone RA; Sansone LA
    Pharmacopsychiatry; 2009 Sep; 42(5):203-4. PubMed ID: 19724984
    [No Abstract]   [Full Text] [Related]  

  • 25. Recurrent hyponatremia associated with citalopram and mirtazapine.
    Bavbek N; Kargili A; Akcay A; Kaya A
    Am J Kidney Dis; 2006 Oct; 48(4):e61-2. PubMed ID: 16997047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Escitalopram-induced word finding difficulty.
    Yang HM; Lee WK; Chang SW; Chiu NM; Huang JH
    Gen Hosp Psychiatry; 2013; 35(1):103.e5-6. PubMed ID: 22632927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perceptual disturbances associated with low-dose bupropion sustained-release treatment.
    Liu CY; Chien YS
    J Clin Psychopharmacol; 2007 Oct; 27(5):543-4. PubMed ID: 17873707
    [No Abstract]   [Full Text] [Related]  

  • 28. Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.
    Pae CU; Lim HK; Han C; Patkar AA; Steffens DC; Masand PS; Lee C
    Expert Rev Neurother; 2007 Oct; 7(10):1251-63. PubMed ID: 17939764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reboxetine and hyponatremia.
    Ranieri P; Franzoni S; Trabucchi M
    N Engl J Med; 2000 Jan; 342(3):215-6. PubMed ID: 10651558
    [No Abstract]   [Full Text] [Related]  

  • 30. Major depressive disorder, antidepressants, and sexual dysfunction.
    Clayton AH; Montejo AL
    J Clin Psychiatry; 2006; 67 Suppl 6():33-7. PubMed ID: 16848675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Augmentation of venlafaxine with bupropion: risks associated with a triple monoamine reuptake inhibition approach to partially responsive depression.
    Andrade C
    J Clin Psychiatry; 2013 Feb; 74(2):e119-21. PubMed ID: 23473356
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety in the use of antidepressants: Vortioxetine-induce hyponatremia in a case report.
    Pelayo-Terán JM; Martínez-Pérez MM; Zapico-Merayo Y
    Rev Psiquiatr Salud Ment; 2017; 10(4):219-220. PubMed ID: 28844296
    [No Abstract]   [Full Text] [Related]  

  • 33. Restless legs syndrome induced by citalopram: a psychiatric emergency?
    Perroud N; Lazignac C; Baleydier B; Cicotti A; Maris S; Damsa C
    Gen Hosp Psychiatry; 2007; 29(1):72-4. PubMed ID: 17189751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyponatremia in relation to treatment with antidepressants: a survey of reports in the World Health Organization data base for spontaneous reporting of adverse drug reactions.
    Spigset O; Hedenmalm K
    Pharmacotherapy; 1997; 17(2):348-52. PubMed ID: 9085327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
    Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
    Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mixed-type (limb-truncal and orofacial) bupropion-associated dyskinesia.
    Ferentinos P; Christodoulou C; Rizos E; Douzenis A; Lykouras L
    J Clin Psychopharmacol; 2010 Oct; 30(5):644-6. PubMed ID: 20841971
    [No Abstract]   [Full Text] [Related]  

  • 37. A case of bupropion-associated delirium.
    Dager SR; Heritch AJ
    J Clin Psychiatry; 1990 Jul; 51(7):307-8. PubMed ID: 2114399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial.
    Cook IA; Hunter AM; Gilmer WS; Iosifescu DV; Zisook S; Burgoyne KS; Howland RH; Trivedi MH; Jain R; Greenwald S; Leuchter AF
    J Clin Psychiatry; 2013 Jan; 74(1):51-6. PubMed ID: 23419226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body dysmorphic disorder treated with bupropion: cases report.
    Nardi AE; Lopes FL; Valença AM
    Aust N Z J Psychiatry; 2005; 39(1-2):112. PubMed ID: 15660717
    [No Abstract]   [Full Text] [Related]  

  • 40. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.